(Q53899617)

22 May 2018

title

[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy] (English)

1 reference

22 May 2018

eradication of infectious diseases

main subject

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

Sicilia B

1

1 reference

22 May 2018

Sierra E

2

1 reference

22 May 2018

Lago A

3

1 reference

22 May 2018

Villar M

4

1 reference

22 May 2018

García S

5

1 reference

22 May 2018

Gomollón F

6

1 reference

22 May 2018

publication date

1 November 2000

1 reference

22 May 2018

published in

Medicina clínica

1 reference

22 May 2018

volume

115

1 reference

22 May 2018

issue

17

1 reference

22 May 2018

page(s)

641-643

1 reference

22 May 2018

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Eradication of Helicobacter pylori Infection With Proton Pump-Based Triple Therapy in Patients in Whom Bismuth-Based Triple Therapy Failed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Re-treatment after Helicobacter pylori eradication failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Regular review: treatment of Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la Conferencia Española de Consenso

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2800%2971649-6

10.1016/S0025-7753(00)71649-6

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018